Fabio Eisfeld: Plasma-derived Drugs Cannot Be Produced Synthetically, They Depend Entirely On The Generosity of Healthy Donors
Fabio Eisfeld, HR Manager Latam at Grifols, shared on LinkedIn:
”Last week, we celebrated International Plasma Awareness Week (IPAW2025 ), and Grifols employees in Latin America actively participated!
Here are photos of colleagues dressed in yellow to contribute to this important moment.
Created by the Plasma Protein Therapeutics Association (PPTA), IPAW is dedicated to highlighting the value of human plasma, recognizing the generosity of donors, and promoting understanding of plasma-derived therapies.
Plasma-derived drugs cannot be produced synthetically; they depend entirely on the generosity of healthy donors.
These donations provide essential proteins, which often represent the only therapy available to patients.
Millions of people around the world, both those suffering from rare and chronic diseases and those facing trauma or medical emergencies, rely on plasma-derived therapies.
We remain firm in our goal: to produce and deliver medicines that provide quality of life to our patients!”
-
Nov 27, 2025, 16:00Nathan Connell on WFH AI Summaries from the Global Forum
-
Nov 27, 2025, 15:49Piotr Czempik: Rethinking Coagulation in Acute Liver Dysfunction
-
Nov 27, 2025, 15:35Overwhelmed? A Leader’s Guide from Mark Crowther to Getting Back on Track
-
Nov 27, 2025, 15:10Wolfgang Miesbach’s Top 10 Picks for TTP and Thrombosis from ASH 2025
-
Nov 27, 2025, 14:24ICCBBA’s Executive Director Eoin McGrath Chairs a Dynamic Session on AI, Innovation and Informatics in Transfusion Medicine
-
Nov 27, 2025, 13:26Wolfgang Miesbach’s Top 10 Picks for Bleeding Disorders from ASH 2025
-
Nov 27, 2025, 11:19Priya Prasad Presents a Case of Severe Hypotensive Transfusion Reaction
-
Nov 27, 2025, 04:07Eugene Tang Presents Highlights from UK Stroke Forum 2025
-
Nov 27, 2025, 03:47Michael Makris: I Believe the Time Has Come to Consider Emicizumab Up Front in Persons with Acquired Hemophilia